Eli Lilly & Co. agreed to buy Verve Therapeutics Inc., a US biotech that’s seeking to use gene editing to prevent clogged arteries, for as much as $1.3 billion.

Eli Lilly to Acquire Gene-Editing Therapy Developer Verve Therapeutics for up to $1.3 Billion, Companies Say (Reuters) -Eli Lilly will acquire Verve Therapeutics for up to $1.3 billion, the ...

Photoelectric memristors, with the advantages of low-power consumption, high scalability and high parallelism, have provided a way for broadening the application of memristors. Photoelectric ...

McDonald’s has been hit by sharp increases in the cost of ingredients and staff in recent years, forcing the chain to raise prices, angering customers in the process. The price of a Big Mac has ...

To deploy a broken-heart emoji in a serious context is a little cringe, as it could be seen as trying to milk guilt out of someone (and FWIW, a phone call is much better for that type of situation).

Coming from Sony Pictures Animation, prepare to venture inside your phone as a society made up of emoji is threatened with deletion when Gene the ‘meh' emoji (Tj Miller) displays more than one emotion ...

Using a tool called Automated Meiotic Mapping (AMM) that was developed at UT Southwestern Medical Center, a team of researchers has identified a gene that appears to be key to regulating food intake.

FDA reassures rare disease advocates that ‘being flexible’ is plan for gene therapy At roundtable, Kennedy, Prasad, and others express openness to quick approvals Adobe By Jason Mast June 6, 2025 ...

Community gathers to honor Burleson County Sheriff Gene Hermes “There’s no doubt in my heart where Gene is today. He loved the Lord, he loved people, and he loved this county.” ...

Prasad, who in the past has criticized the FDA’s accelerated approval of a gene therapy for Duchenne muscular dystrophy, showed support for flexible trial designs and endpoints when appropriate for ...

Nine-month-old KJ Muldoon is the first patient to successfully receive personalized CRISPR gene editing therapy. After 300 days in the hospital, baby KJ has returned home.

Baby KJ Muldoon was born with a rare genetic disorder called CPS1 deficiency and spent nearly the entire first year of his life in the hospital. Now, he’s finally home after becoming the first ...